HALEON PLC-ADR (HLN) Stock Price, Forecast & Analysis
USA - New York Stock Exchange - NYSE:HLN - US4055521003 - ADR
HLN Key Statistics, Chart & Performance
The current stock price of HLN is 9.76 USD. In the past month the price increased by 7.85%. In the past year, price increased by 1.04%.
HLN Latest News, Press Relases and Analysis
HLN Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 50.22 | 1.05T | ||
| JNJ | JOHNSON & JOHNSON | 20 | 499.88B | ||
| MRK | MERCK & CO. INC. | 11.88 | 261.34B | ||
| PFE | PFIZER INC | 8.03 | 146.18B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 7.51 | 100.25B | ||
| ZTS | ZOETIS INC | 20.14 | 56.59B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 9.69 | 23.23B | ||
| VTRS | VIATRIS INC | 4.57 | 12.40B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 24.28 | 11.58B | ||
| CORT | CORCEPT THERAPEUTICS INC | 90.68 | 8.39B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 7.53B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 4.52B |
Related stock screener links
About HLN
Company Profile
Haleon Plc engages in the provision of personal healthcare products. The company is headquartered in Weybridge, Surrey and currently employs 24,000 full-time employees. The company went IPO on 2022-07-18. The Company’s product portfolio spans six major categories, including oral health, vitamins, minerals and supplements (VMS), pain relief, respiratory health, digestive health and therapeutic skin health and other. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA) & LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company’s oral health brands include Sensodyne, Polident, and Parodontax. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, Flonase, Contac, and Beechams. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Benefiber. Its therapeutic skin health brands include Fenistil, Zovirax, and Bactroban.
Company Info
HALEON PLC-ADR
Building 5, First Floor, The Heights
Weybridge SURREY GB
Employees: 24000
Phone: 441932822000
HALEON PLC-ADR / HLN FAQ
Can you describe the business of HALEON PLC-ADR?
Haleon Plc engages in the provision of personal healthcare products. The company is headquartered in Weybridge, Surrey and currently employs 24,000 full-time employees. The company went IPO on 2022-07-18. The Company’s product portfolio spans six major categories, including oral health, vitamins, minerals and supplements (VMS), pain relief, respiratory health, digestive health and therapeutic skin health and other. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA) & LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company’s oral health brands include Sensodyne, Polident, and Parodontax. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, Flonase, Contac, and Beechams. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Benefiber. Its therapeutic skin health brands include Fenistil, Zovirax, and Bactroban.
What is the current price of HLN stock?
The current stock price of HLN is 9.76 USD. The price decreased by -0.61% in the last trading session.
Does HALEON PLC-ADR pay dividends?
HALEON PLC-ADR (HLN) has a dividend yield of 1.84%. The yearly dividend amount is currently 0.17.
How is the ChartMill rating for HALEON PLC-ADR?
HLN has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
When is the next dividend date for HALEON PLC-ADR (HLN)?
The next ex-dividend date for HALEON PLC-ADR (HLN) is August 15, 2025.
What is HALEON PLC-ADR worth?
HALEON PLC-ADR (HLN) has a market capitalization of 43.46B USD. This makes HLN a Large Cap stock.
What is the ownership structure of HALEON PLC-ADR (HLN)?
You can find the ownership structure of HALEON PLC-ADR (HLN) on the Ownership tab.
HLN Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to HLN. When comparing the yearly performance of all stocks, HLN turns out to be only a medium performer in the overall market: it outperformed 47.45% of all stocks.
HLN Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to HLN. HLN scores excellent on profitability, but there are some minor concerns on its financial health.
HLN Financial Highlights
Over the last trailing twelve months HLN reported a non-GAAP Earnings per Share(EPS) of 0.49. The EPS increased by 6.59% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 12.84% | ||
| ROA | 4.2% | ||
| ROE | 8.92% | ||
| Debt/Equity | 0.53 |
HLN Forecast & Estimates
25 analysts have analysed HLN and the average price target is 11.2 USD. This implies a price increase of 14.73% is expected in the next year compared to the current price of 9.76.
For the next year, analysts expect an EPS growth of 5.41% and a revenue growth -1.43% for HLN